- Report
- June 2023
- 115 Pages
Global
From €4047EUR$4,500USD£3,490GBP
- Report
- May 2023
- 116 Pages
Global
From €4047EUR$4,500USD£3,490GBP
- Report
- April 2023
- 116 Pages
Global
From €4047EUR$4,500USD£3,490GBP
- Report
- August 2022
- 120 Pages
Global
From €4047EUR$4,500USD£3,490GBP
- Report
- March 2026
- 299 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- March 2026
- 301 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- March 2026
- 292 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- February 2026
- 296 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- February 2026
- 305 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 290 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 291 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 275 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 290 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 286 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 275 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 286 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 277 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 281 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 299 Pages
Global
From €2248EUR$2,500USD£1,939GBP
- Report
- January 2026
- 281 Pages
Global
From €2248EUR$2,500USD£1,939GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more